1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 301.1K | - |
| Gross profit | 294.21K | 2,343.50% |
| Net profit | -2.47M | 56.63% |
| EBITDA | -2.37M | 53.93% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €13.33M |
Number of shares | 40.63M |
52-week high/low | €2.24 - €0.21 |
| Dividends | No |
Beta | 3.96 |
P/E ratio | -0.21 |
PEG ratio | -0.02 |
P/B ratio | 0.00 |
P/S ratio | 18.80 |
Company profile
TRxADE HEALTH, Inc. ist ein IT-Unternehmen für Gesundheitsdienstleistungen. Es bietet eine webbasierte Online-Kauf- und Verkaufsplattform für lizenzierte Pharmagroßhändler, die Markenprodukte, Generika und nichtmedikamentöse Produkte und Dienstleistungen an Regierungsorganisationen, Krankenhäuser, Kliniken und unabhängige Apotheken verkaufen. TRxADE HEALTH, Inc. hat seinen Hauptsitz in Tampa, Florida.
| Name | Scienture Holdings Inc |
| CEO | Shankar Hariharan |
| Headquarters | Commack,
ny USA |
| Website | |
| IPO | 02/06/2014 |
| Employees | 9 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | SCNX |
Discover assets
Shareholders of Scienture Holdings Inc also invest in the following assets
